Economics of Innovation
Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.
Health Systems Performance Assessment
1 April 2006
Annual lecture by Christopher Murray, who speaks in the UK about the work on health systems performance assessment (HSPA) at the World Health Organization. He gives…
The Many Faces of Innovation
2 January 2005
The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at…
Childhood and Adolescent Mental Health: Understanding the Lifetime Impacts
1 January 2005
I suspect most of us who have had anything to do with the issues surrounding young people’s mental health believe that resolving issues in early life…
Institutions for Industrial Competitiveness in the International Pharmaceutical Industry
3 January 2003
One of the main characteristics of the pharmaceutical industry, including biotechnology, is the important role played by public institutions. Their role is not only focused on…
Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty
1 December 2002
Improving the health and life expectancy of the populations of the less developed countries of the world requires both better access to medicines and research and…
The Life Cycle of Pharmaceuticals: A Cross-National Perspective
1 April 2002
This study provides a life cycle perspective on cross-national differences in pharmaceutical prices, volumes and expenditures. Most previous studies have focused solely on cross-national differences in…
Consolidation and Competition in the Pharmaceutical Industry
9 January 2001
A number of potentially important structural developments are taking place in the pharmaceutical industry. On the one hand, we are witnessing a large number of mergers…
Capturing the Unexpected Benefits of Medical Research
5 January 2001
It has long been known that a medicine may turn out to have an unexpected beneficial effect on an illness other than the one it was…
The Road to Sustainability in the UK and German Biotechnology Industries
1 August 2000
The UK and Germany are the European leaders in biotechnology. They have many more companies and employees in biotechnology, and much greater sums invested in biotechnology…